- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04557241
Brief Informational Intervention for COVID-19 Misinformation Prophylaxis
As the coronavirus disease 2019 (COVID-19) pandemic has continued to affect life in the United States, the important role of non-pharmaceutical preventive behaviors (such as wearing a face mask) in reducing harm has become clear. In parallel to the pandemic, researchers have observed an "infodemic" of misinformed or inconsistent narratives about COVID-19. There is growing evidence that misinformed COVID-19 narratives are associated with a wide variety of undesirable behavior (e.g., burning down cell towers). Further, individuals' adherence to recommended COVID-19 preventive guidelines has been inconsistent, and such mandates have engendered opposition and controversy. Recent research suggests the possibility that trust in science and scientists may be an important thread to weave throughout these seemingly disparate components of the modern public health landscape. Thus, this paper describes the protocol for a randomized trial of a brief, digital intervention to increase trust in science.
The objective of this trial is to examine if exposure to a curated infographic can increase trust in science, reduce believability of misinformed narratives, and increase likelihood to engage in preventive behaviors.
Visão geral do estudo
Status
Condições
Descrição detalhada
The investigators propose a single-stage, randomized, superiority trial with 2 parallel groups allocated with a 1:1 ratio. The comparator in this study will be a control ("placebo") infographic that is completely unrelated to science (e.g., about cats), but that is developed using the same communication and graphical style.
Subjects will be recruited using the Prolific data collection platform, which is one of two primary online crowdsourced research platforms (the other is Amazon's Mechanical Turk, or mTurk).
To be included, participants must be identified by Prolific as part of a nationally-representative sample. Participants will also be required to be age 18 or older, and to reside in the United States. Individuals who decline to digitally sign the informed consent document will be excluded and replaced. Per recent best practice recommendations for crowdsourced digital research, attention checks and screens for "bots" and international users with virtual private networks to mimic US IP addresses will be embedded within the instruments, and failure of more than one attention check, or any bot/location check will result in subject exclusion and replacement. Replacements will be drawn in such a way as to preserve the representativeness of the sample.
Missing data will be addressed using either full information maximum likelihood or Markov Chain Monte Carlo multiple imputation strategies. When there is a violation of missing at random (which is unlikely) in preliminary analyses, the investigators will incorporate strategies representing the missingness. The researchers will further explore data quality in terms of outliers, measurement error, non-normality, and variance heterogeneity. Robust methods of analysis (e.g., Huber-White robust standard errors) will be used, as appropriate. For all multi-item measures, reliability will be evaluated prior to computation of the variable.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Indiana
-
Bloomington, Indiana, Estados Unidos, 47404
- Digital Intervention (Prolific Study Panel)
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- To be included, participants must be identified by Prolific as part of a nationally-representative sample. Participants will also be required to be age 18 or older, and to reside in the United States.
Exclusion Criteria:
- Individuals who decline to digitally sign the informed consent document will be excluded and replaced. Per recent best practice recommendations for crowdsourced digital research, attention checks and screens for "bots" and international users with virtual private networks to mimic US internet protocol addresses will be embedded within the instruments, and failure of more than one attention check, or any bot/location check will result in subject exclusion and replacement.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Brief Intervention arm
The primary intervention in this study will be an infographic that is designed to build trust in the scientific process (as described in the Intervention section).
This arm will introduce the intervention and then instruct the participant to review it carefully (including a mandated pause on the infographic screen) before continuing to the remaining data collection.
|
The primary intervention in this study will be an infographic that is designed to build trust in the scientific process.
Infographics are preferable to narratives or text because they center visuals as part of the storytelling process and facilitate cognitive information processing, knowledge absorption, and enhanced persuasion.
The study's infographic design will follow best practices in health communication.
The message will be simple and jargon free.
Visuals will include individuals (scientists), charts, text, and numbers.
Attention will be paid to images, color, frames, representation, and composition (e.g., how the elements in the infographic are organized to show their relationship to each other).
|
Comparador de Placebo: Placebo Control arm
The comparator in this study will be a control ("placebo") infographic that is completely unrelated to science (As described in the Placebo Control section).
This arm will introduce the control infographic and then instruct the participant to review it carefully (including a mandated pause on the infographic screen) before continuing to the remaining data collection.
|
The comparator in this study will be a control ("placebo") infographic that is completely unrelated to science (e.g., about cats), but that is developed using the same communication and graphical style.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in trust in science
Prazo: Pre-intervention and immediately post-intervention
|
21-item scale developed by Nadelson et al [1] called the Trust in Science Inventory.
It is scored from 1 to 5, where 1 indicates low trust and 5 indicates high trust.
|
Pre-intervention and immediately post-intervention
|
Believability profiles
Prazo: Immediately post-intervention
|
Will be computed using latent profile analysis of believability measures.
These measures were developed and first used in our recent study of COVID-19 narratives [2].
Response options for these measures used well-established semantic differential responses for believability of different statements (e.g., as in Herzberg et al.) [3] ranging from [1: Extremely unbelievable] to [7: Extremely believable].
Exact measures used to generate profiles for this study will be available in the published protocol paper (to be submitted).
|
Immediately post-intervention
|
Preventive behavioral intentions
Prazo: Immediately post-intervention
|
A series of six questions based on the US Centers for Disease Control and Prevention's recommended COVID-19 preventive behaviors.
[4] Questions will be written according to Azjen's guide to intention questionnaires [5].
|
Immediately post-intervention
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Political orientation (covariate 1)
Prazo: Immediately post-intervention
|
Scale variable (0: Conservative to 10: Liberal) as in our prior work [2, 6]
|
Immediately post-intervention
|
Religious commitment (covariate 2)
Prazo: Immediately post-intervention
|
Scale variable (0: Low commitment to 10: High commitment) as in our prior work [2, 6]
|
Immediately post-intervention
|
Sociodemographics (covariates 3 through 6)
Prazo: Immediately post-intervention
|
Race/ethnicity, gender, age, and education level using standardized questions
|
Immediately post-intervention
|
COVID-19 diagnosis (covariates 7 and 8)
Prazo: Immediately post-intervention
|
Two self report questions.
The first asks whether the respondent has been diagnosed with COVID-19, and the second asks more broadly whether the respondent believes they have had COVID-19.
Question wording will be per Bruine de Bruin (2020) [7].
|
Immediately post-intervention
|
Perceived severity of COVID-19 (covariate 9)
Prazo: Immediately post-intervention
|
Based on the Health Belief Model as used in Yıldırıma & Gülerc [8].
|
Immediately post-intervention
|
Self-efficacy to act regarding COVID-19
Prazo: Immediately post-intervention
|
Based on the Health Belief Model as used in Yıldırıma & Gülerc [8].
|
Immediately post-intervention
|
Normative beliefs about friends' and family's COVID-19 behaviors
Prazo: Immediately post-intervention
|
Single item from Chambon et al [9].
|
Immediately post-intervention
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Publicações e links úteis
Publicações Gerais
- Herzberg KN, Sheppard SC, Forsyth JP, Crede M, Earleywine M, Eifert GH. The Believability of Anxious Feelings and Thoughts Questionnaire (BAFT): a psychometric evaluation of cognitive fusion in a nonclinical and highly anxious community sample. Psychol Assess. 2012 Dec;24(4):877-91. doi: 10.1037/a0027782. Epub 2012 Apr 9.
- Nadelson L, Jorcyk C, Yang D, et al. I just don't trust them: The development and validation of an assessment instrument to measure trust in science and scientists. School Science and Mathematics. 2014;114(2):76-86.
- Agley J, Xiao Y. Existence of differential belief profiles of COVID-19 narratives: The role of trust in science. Research Square. 2020;Preprint.
- CDC. How to protect yourself & others. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Published 2020. Accessed July 17, 2020.
- Ajzen I. Theory of planned behavior questionnaire. Measurement Instrument Database for Social Science. https://www.midss.org/sites/default/files/tpb.construction.pdf. Published 2013. Accessed July 17, 2020.
- Agley J. Assessing changes in US public trust in science amid the COVID-19 pandemic. Public Health. 2020 Jun;183:122-125. doi: 10.1016/j.puhe.2020.05.004. Epub 2020 May 13.
- Bruine de Bruin W. Age Differences in COVID-19 Risk Perceptions and Mental Health: Evidence From a National U.S. Survey Conducted in March 2020. J Gerontol B Psychol Sci Soc Sci. 2021 Jan 18;76(2):e24-e29. doi: 10.1093/geronb/gbaa074.
- Yildirim M, Guler A. COVID-19 severity, self-efficacy, knowledge, preventive behaviors, and mental health in Turkey. Death Stud. 2022;46(4):979-986. doi: 10.1080/07481187.2020.1793434. Epub 2020 Jul 16.
- Chambon M, Dalege J, Elberse JE, Harreveld Fv. A psychological network approach to factors related to preventive behaviors during pandemics: A European COVID-19 study. PsyArXiv. 2020:https://doi.org/10.31234/osf.io/es31245v.
- Agley J, Xiao Y, Thompson EE, Chen X, Golzarri-Arroyo L. Intervening on Trust in Science to Reduce Belief in COVID-19 Misinformation and Increase COVID-19 Preventive Behavioral Intentions: Randomized Controlled Trial. J Med Internet Res. 2021 Oct 14;23(10):e32425. doi: 10.2196/32425.
- Agley J, Xiao Y, Thompson EE, Golzarri-Arroyo L. COVID-19 Misinformation Prophylaxis: Protocol for a Randomized Trial of a Brief Informational Intervention. JMIR Res Protoc. 2020 Dec 7;9(12):e24383. doi: 10.2196/24383.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Indiana_CTSI_Agley_2020
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em COVID19 Behavioral Prophylaxis
-
Anavasi DiagnosticsAinda não está recrutando
-
Ain Shams UniversityRecrutamento
-
Israel Institute for Biological Research (IIBR)Concluído
-
Colgate PalmoliveConcluído
-
Christian von BuchwaldConcluído
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdAtivo, não recrutando
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichInscrevendo-se por convite
-
Alexandria UniversityConcluído
Ensaios clínicos em Brief informational infographic
-
University of SalamancaConcluído
-
Assistance Publique - Hôpitaux de ParisAinda não está recrutandoDistúrbios do Neurodesenvolvimento
-
Ankara Yildirim Beyazıt UniversityRecrutamentoDor musculoesquelética | QuestionárioPeru
-
UNC Lineberger Comprehensive Cancer CenterConcluídoCâncer de mama | MetástaseEstados Unidos
-
Assistance Publique - Hôpitaux de ParisRecrutamentoSíndrome de Ondina | Síndrome de Hipoventilação Central Congênita (CCHS)França
-
University Hospital, CaenConcluídoDistúrbios do Neurodesenvolvimento | Comportamento infantilFrança
-
Universitaire Ziekenhuizen KU LeuvenUniversity Hospital, Ghent; Gasthuis Zusters AntwerpenRecrutamentoGlioma | Adenoma hipofisário | Tumor cerebral | Imagem de ressonância magnética | Meningioma | ConhecimentoBélgica
-
VA Boston Healthcare SystemRecrutamentoTEPT | TCE (lesão cerebral traumática)Estados Unidos